Yili Chuannig Biotechnology Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Yili Chuannig Biotechnology Co., Ltd.

Why is Yili Chuannig Biotechnology Co., Ltd. ?

With a fall in Net Sales of -15.61%, the company declared Very Negative results in Mar 26

The company has declared negative results for the last 4 consecutive quarters
OPERATING CASH FLOW(Y) Lowest at CNY 615.15 MM
ROCE(HY) Lowest at 7.22%
INTEREST(Q) At CNY 8.93 MM has Grown at 197.76%

Below par performance in long term as well as near term

Along with generating -33.72% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Yili Chuannig Biotechnology Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Yili Chuannig Biotechnology Co., Ltd.

-33.72%

-1.45

27.29%

China Shanghai Composite

16.78%

1.20

13.96%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.33%

EBIT Growth (5y)

28.45%

EBIT to Interest (avg)

85.34

Debt to EBITDA (avg)

0.69

Net Debt to Equity (avg)

-0.01

Sales to Capital Employed (avg)

0.57

Tax Ratio

16.66%

Dividend Payout Ratio

50.14%

Pledged Shares

Institutional Holding

ROCE (avg)

7,093.73%

ROE (avg)

3,839.06%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.63

EV to EBIT

6.78

EV to EBITDA

4.31

EV to Capital Employed

0.63

EV to Sales

1.19

PEG Ratio

Dividend Yield

5.29%

ROCE (Latest)

9.29%

ROE (Latest)

7.23%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-39What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 615.15 MM

ROCE(HY)

Lowest at 7.22%

INTEREST(Q)

At CNY 8.93 MM has Grown at 197.76%

INTEREST COVERAGE RATIO(Q)

Lowest at 1,732.89

OPERATING PROFIT(Q)

Lowest at CNY 154.73 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 14.14 %

PRE-TAX PROFIT(Q)

Lowest at CNY 141.87 MM

NET PROFIT(Q)

Lowest at CNY 111.44 MM

RAW MATERIAL COST(Y)

Grown by 36.25% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.66 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.23 times

NET SALES(Q)

Fallen at -15.61%

EPS(Q)

Lowest at CNY 0.05

Here's what is not working for Yili Chuannig Biotechnology Co., Ltd.

Pre-Tax Profit

At CNY 141.87 MM has Fallen at -59.54%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 111.44 MM has Fallen at -61.33%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

At CNY 8.93 MM has Grown at 197.76%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 1,732.89

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit

Lowest at CNY 154.73 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 14.14 % and Fallen

In each period in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY 141.87 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 111.44 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 615.15 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Fallen at -15.61%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

EPS

Lowest at CNY 0.05

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio

Lowest at 2.66 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 2.23 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 36.25% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales